StockData
Xenetic Biosciences, Inc. logo

Xenetic Biosciences, Inc. (XBIO) stock

XBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 12/3064% below fair value
$1.61+0.12 (+8.05%)

Close on Nov 17, 2026Market cap $3.77MP/E –Yield –

Xenetic Biosciences r&d expenses

Research and development expenses are spending on new products and technology.

Xenetic Biosciences's R&D Expenses for the twelve months ending Jun 30, 2026 was $2.74M, down 6.9% year over year. For fiscal 2025 it was $3.07M, down 6.8% from the year before. Over ten years it grew -1.1% a year on average. The highest annual figure on record is $43.74M in fiscal 2016.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$3.07M-6.8%
FY2024Dec 31, 2024$3.29M-5.9%
FY2023Dec 31, 2023$3.49M-26.7%
FY2022Dec 31, 2022$4.77M+50.8%
FY2021Dec 31, 2021$3.16M+82.7%
FY2020Dec 31, 2020$1.73M-64.6%
FY2019Dec 31, 2019$4.89M+69.5%
FY2018Dec 31, 2018$2.88M-29.0%
FY2017Dec 31, 2017$4.06M-90.7%
FY2016Dec 31, 2016$43.74M+1173.7%
FY2015Dec 31, 2015$3.43M-45.7%
FY2014Dec 31, 2014$6.32M+106.6%
FY2013Dec 31, 2013$3.06M+57.5%
FY2012Dec 31, 2012$1.94M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$552.01K-15.9%
Q1 FY2026Mar 31, 2026$661.44K-24.8%
Q4 FY2025Dec 31, 2025$773.42K-25.8%
Q3 FY2025Sep 30, 2025$756.48K+105.6%
Q2 FY2025Jun 30, 2025$656.56K-29.7%
Q1 FY2025Mar 31, 2025$879.03K-6.9%
Q4 FY2024Dec 31, 2024$1.04M+6.8%
Q3 FY2024Sep 30, 2024$367.99K-63.9%
Q2 FY2024Jun 30, 2024$933.77K+3.4%
Q1 FY2024Mar 31, 2024$944.32K+58.6%
Q4 FY2023Dec 31, 2023$975.63K-53.0%
Q3 FY2023Sep 30, 2023$1.02M-7.3%
Q2 FY2023Jun 30, 2023$903.24K-26.5%
Q1 FY2023Mar 31, 2023$595.28K-23.7%
Q2 FY2022Jun 30, 2022$2.08M+296.1%
Q1 FY2022Mar 31, 2022$1.10M+74.9%
Q4 FY2021Dec 31, 2021$1.23M+150.4%
Q3 FY2021Sep 30, 2021$780.15K+36.1%
Q2 FY2021Jun 30, 2021$524.55K+70.4%
Q1 FY2021Mar 31, 2021$629.73K+75.1%
Q4 FY2020Dec 31, 2020$490.79K+17.6%
Q3 FY2020Sep 30, 2020$573.06K-83.7%
Q2 FY2020Jun 30, 2020$307.90K-36.8%
Q1 FY2020Mar 31, 2020$359.65K-22.5%
Q4 FY2019Dec 31, 2019$417.40K-18.9%
Q3 FY2019Sep 30, 2019$3.52M+378.4%
Q2 FY2019Jun 30, 2019$487.52K-47.4%
Q1 FY2019Mar 31, 2019$463.78K-34.3%
Q4 FY2018Dec 31, 2018$514.73K-52.3%
Q3 FY2018Sep 30, 2018$735.88K-16.8%
Q2 FY2018Jun 30, 2018$927.07K+6.1%
Q1 FY2018Mar 31, 2018$706.27K-42.2%
Q4 FY2017Dec 31, 2017$1.08M-97.3%
Q3 FY2017Sep 30, 2017$884.80K-0.8%
Q2 FY2017Jun 30, 2017$873.84K-60.4%
Q1 FY2017Mar 31, 2017$1.22M–
Q4 FY2016Dec 31, 2016$40.21M–
Q3 FY2016Sep 30, 2016$891.83K–
Q2 FY2016Jun 30, 2016$2.21M–

More Xenetic Biosciences figures

See a number that looks wrong?